Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_007294.4(BRCA1):c.3759_3760delTA(p.Lys1254GlufsTer12) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★★). Synonymous variant affecting the same amino acid position (i.e. S1253S) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
BRCA1-related cancer predisposition
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
breast-ovarian cancer, familial, susceptibility to, 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
Our verdict: Pathogenic. The variant received 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-43091770-TTA-T is Pathogenic according to our data. Variant chr17-43091770-TTA-T is described in ClinVar as Pathogenic. ClinVar VariationId is 37544.Status of the report is reviewed_by_expert_panel, 3 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Sel.
Gene
Transcript
Tags
HGVSc
HGVSp
Effect
Exon Rank
Protein
UniProt
BRCA1
NM_007294.4
MANE Select
c.3759_3760delTA
p.Lys1254GlufsTer12
frameshift
Exon 10 of 23
NP_009225.1
P38398-1
BRCA1
NM_001407581.1
c.3759_3760delTA
p.Lys1254GlufsTer12
frameshift
Exon 10 of 24
NP_001394510.1
A0A2R8Y7V5
BRCA1
NM_001407582.1
c.3759_3760delTA
p.Lys1254GlufsTer12
frameshift
Exon 10 of 24
NP_001394511.1
A0A2R8Y7V5
Ensembl Transcripts
Sel.
Gene
Transcript
Tags
HGVSc
HGVSp
Effect
Exon Rank
Protein
UniProt
BRCA1
ENST00000357654.9
TSL:1 MANE Select
c.3759_3760delTA
p.Lys1254GlufsTer12
frameshift
Exon 10 of 23
ENSP00000350283.3
P38398-1
BRCA1
ENST00000471181.7
TSL:1
c.3759_3760delTA
p.Lys1254GlufsTer12
frameshift
Exon 10 of 24
ENSP00000418960.2
P38398-7
BRCA1
ENST00000470026.6
TSL:1
c.3759_3760delTA
p.Lys1254GlufsTer12
frameshift
Exon 10 of 23
ENSP00000419274.2
P38398-1
Frequencies
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
Breast-ovarian cancer, familial, susceptibility to, 1 (5)
3
-
-
not provided (3)
2
-
-
Hereditary breast ovarian cancer syndrome (2)
2
-
-
Hereditary cancer-predisposing syndrome (2)
1
-
-
Breast-ovarian cancer, familial, susceptibility to, 1;C3280442:Pancreatic cancer, susceptibility to, 4;C4554406:Fanconi anemia, complementation group S (1)
1
-
-
Familial cancer of breast;C2676676:Breast-ovarian cancer, familial, susceptibility to, 1;C3280442:Pancreatic cancer, susceptibility to, 4;C4554406:Fanconi anemia, complementation group S (1)